Equities

Ortivus AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Ortivus AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)1.73
  • Today's Change-0.005 / -0.29%
  • Shares traded6.15k
  • 1 Year change-3.89%
  • Beta0.4700
Data delayed at least 15 minutes, as of Feb 11 2026 17:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.

  • Revenue in SEK (TTM)75.91m
  • Net income in SEK-24.74m
  • Incorporated1985
  • Employees34.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Observe Medical ASA15.64m-115.27m87.04m4.00--3.59--5.57-26.57-26.573.290.19090.11182.878.293,350,800.00-82.38-42.22-205.00-64.146.2430.17-737.14-327.970.1175-3.720.9572---33.85153.47-98.73---2.97--
BibbInstruments AB149.00k-13.30m88.81m4.00--2.08--596.05-0.3802-0.38020.00411.050.00382.062.7137,250.00-33.98-36.85-35.53-40.0630.8759.14-8,922.82-22,555.646.67--0.00-------15.85---1.52--
SyntheticMR AB (publ)57.05m-54.93m101.39m41.00--0.6871--1.78-0.9057-0.90570.94671.650.3678--0.87331,391,415.00-35.42-7.92-51.34-10.5110.4156.07-96.28-14.37---8.730.0450--2.473.20-241.50--7.37--
Arcoma AB132.94m4.35m107.03m31.0023.341.469.240.80510.32050.32059.875.131.452.9213.714,288,452.004.752.166.663.7540.4537.953.271.402.04--0.000.00-3.813.24336.0011.08-9.43--
Iconovo AB1.59m-41.23m107.71m19.00--0.4547--67.88-1.67-1.670.05372.460.0117--0.260863,475.20-30.39-28.39-33.14-31.51901.69159.24-2,598.41-295.86---138.020.0391---58.55-24.2210.36--22.28--
Immunovia AB (publ)785.00k-125.52m127.13m9.00------161.95-0.3569-0.35690.0024-0.0210.0156--0.26487,222.22-249.16-48.08-827.53-52.27-7,231.59-6,932.30-15,989.68-17,625.510.6282-3.001.68---40.8921.2075.26------
Scandinavian Real Heart AB0.00-38.87m137.96m12.00--0.8266-----16.17-16.170.0016.690.00----0.00-44.53-27.49-52.77-30.65-------12,518.77----0.0678------49.47--6.59--
Bioretec Oy-1.06tn-1.06tn141.91m57.00---------------------------57.56---77.31--70.90---128.20--------16.3221.07-21.78------
Scandinavian Medical Solutions A/S347.28m36.79k150.68m28.005,803.031.2812.170.43390.00070.00078.882.991.291.9411.19--0.01376.590.024611.6823.1224.880.01064.680.35241.140.4345--8.2842.38-99.67-64.34----
Ortivus AB75.91m-24.74m150.86m34.00------1.99-0.5583-0.55831.71-0.50621.186.7716.222,372,281.00-38.46-4.62-147.30-8.6534.7941.27-32.59-3.550.4719-4.011.72---4.369.60-36.49--65.37--
Bactiquant A/S11.69m-18.51m160.86m----11.13--13.76-0.4696-0.46960.29660.27230.46562.6915.14---73.73-55.41-85.85-64.53-31.80-10.94-158.37-121.813.26-9.700.1926---41.68-14.27-4.72------
iZafe Group AB5.90m-17.73m162.25m10.00--9.86--27.50-0.0614-0.06140.01940.04520.17573.448.15843,000.00-52.78-57.76-73.42-72.44-106.29-287.24-300.41-630.900.9122-17.450.0198--336.55-11.1036.26---24.50--
Micropos Medical AB (publ)8.08m-21.73m190.64m9.00------23.60-0.1398-0.13980.0514-------------83.62---110.96120.0394.59-268.99-558.00---99.12----112.4917.010.7589---16.83--
Boule Diagnostics AB512.66m-80.68m191.84m186.00--1.14--0.3742-2.09-2.0913.334.341.034.614.042,268,420.00-16.14-9.09-28.43-13.2842.8843.62-15.74-11.160.775323.700.5491---2.252.28-1,287.41--7.84--
BrainCool AB (publ)43.62m-36.85m197.44m20.00--1.12--4.53-0.1408-0.14080.16660.44790.28411.152.922,180,769.00-24.00-38.93-26.22-53.1029.8648.00-84.48-233.832.29-33.110.00--72.0556.5028.13--4.34--
Subgen AI AB0.00-64.18m207.78m15.00---------544.10-544.100.00-25.110.00----0.00-188.83---403.12-------------4.46-----100.00--16.86------
Data as of Feb 11 2026. Currency figures normalised to Ortivus AB's reporting currency: Swedish Krona SEK

Institutional shareholders

1.88%Per cent of shares held by top holders
HolderShares% Held
Seligson & Co. Rahastoyhti� Oyjas of 30 Jan 20261.60m1.84%
Evli Fund Management Co. Ltd.as of 30 Aug 202434.32k0.04%
Data from 30 Jan 2026 - 30 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.